Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
Apr 17, 16:00
Stemcell Holdings Cash from Financing (TTM): -0.0934M for Sept. 30, 2018
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2018 | -0.0934M |
| June 30, 2018 | -0.0935M |
| March 31, 2018 | -0.9663M |
| December 31, 2017 | -0.0433M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0003M |
| June 30, 2017 | 0.0017M |
| March 31, 2017 | 0.069M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| AIM ImmunoTech Inc | 0.485M |
| Perspective Therapeutics Inc | 0.785M |
| Protalix BioTherapeutics Inc | 24.67M |
| Electromed Inc | -0.128M |
| Armata Pharmaceuticals Inc | 53.99M |